41 studies found for:    " May 28, 2008":" June 27, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility
Conditions: Candidiasis;   HIV Infections
Intervention:
22 Completed Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
Conditions: Opioid-related Disorders;   HIV Infections;   Hepatitis C, Chronic;   Depression
Interventions: Behavioral: MET/CBT based individualized counseling;   Drug: Buprenorphine
23 Completed VENICE Study Nevirapine Full Dose/Dose Escalation
Condition: HIV Infections
Intervention: Drug: nevirapine
24 Completed Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
Condition: HIV Infections
Interventions: Behavioral: Network leader training;   Behavioral: Standard HIV risk-reduction counseling
25 Active, not recruiting Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations
Condition: HIV Infections
Interventions: Behavioral: Face-to-face training;   Behavioral: Distance training;   Behavioral: Popular Opinion Leader (POL)
26 Completed
Has Results
Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Pre-study antiretroviral regimen
27 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Intervention:
28 Unknown  The Detection of Drug-Resistant HIV-1 in Taiwan
Condition: HIV Infections
Intervention:
29 Completed Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations
Conditions: HIV Infections;   Malaria
Interventions: Drug: lopinavir/ritonavir;   Drug: efavirenz;   Drug: artemether/lumefantrine
30 Completed Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Condition: Tuberculosis (TB)
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
31 Withdrawn Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
Condition: HIV Infection
Intervention:
32 Withdrawn Surveillance Cohort Long-Term Toxicity Antiretrovirals in HIV-Infected Patients Enrolled in TPV Cohort
Condition: HIV Infections
Intervention: Drug: Tipranavir
33 Completed
Has Results
Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
Condition: HIV Infections
Interventions: Biological: (PV) 23-valent pneumococcal polysaccharide vaccine;   Biological: Placebo
34 Completed Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
Condition: HIV Infections
Interventions: Drug: Vicriviroc maleate;   Drug: Placebo;   Drug: Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
35 Completed Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
Intervention: Drug: Maraviroc
36 Completed Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
Conditions: HIV Infections;   Adverse Effects
Intervention: Behavioral: Cognitive-behavioral therapy
37 Completed Linkage to Care - Part I
Condition: HIV
Intervention:
38 Completed TDM of Generic Lopinavir/Ritonavir 200/50 mg
Condition: HIV
Intervention: Drug: generic lopinavir/ritonavir
39 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
40 Terminated
Has Results
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Condition: Kaposi's Sarcoma
Interventions: Drug: VEGF inhibitor PTC299;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years